Related Experiment Video
Updated: Mar 26, 2026
10:21
A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023
2.4K
[THE MODE OF CLARIFYING DIAGNOSTIC OF PROGRESSING FORMS OF OVARIAN CARCINOMA]
Klinicheskaia Laboratornaia Diagnostika
|February 5, 2016
Summary
Oxidative modification of proteins in blood plasma can reliably differentiate between stage III and IV ovarian carcinoma. This finding aids in accurate diagnosis and cost-effective treatment planning for advanced ovarian cancer.
Area of Science:
- Oncology
- Biochemistry
- Medical Diagnostics
Context:
- Ovarian carcinoma is a leading cause of cancer death in women.
- Lack of pathognomonic symptoms complicates early and accurate staging.
- Accurate staging is crucial for treatment selection and cost-effectiveness analysis.
Purpose:
- To develop a diagnostic method for advanced ovarian carcinoma stages (III and IV).
- To evaluate oxidative modification of proteins in blood plasma as a potential biomarker.
- To assess the reliability of 21 blood plasma indicators for ovarian cancer staging.
Summary:
- This study analyzed 21 blood plasma indicators in 100 patients with stage III/IV ovarian carcinoma.
- Indicators included leukocyte counts, protein oxidation products, tumor markers (CA-125, Her-2/neu), MMPs, cytokines, and oxidative stress enzymes.
- Statistical analysis using the least squares method and Rayleigh distribution approximated indicator rates.
Impact:
- Findings suggest that oxidative modification of proteins is a reliable indicator for differentiating stage III and IV ovarian carcinoma.
- This biomarker can improve diagnostic accuracy for advanced disease.
- Enhanced diagnostic capabilities can lead to more effective and cost-efficient patient management.
